Our team of experienced chemists, project managers, and support staff values each client and is dedicated to moving their projects forward. We are family-owned and operated, and our small size allows us to be accessible, responsive, and to act quickly. Customers consider us for our technical expertise and outstanding history of FDA compliance, but they choose us for our engaging people found in every department from purchasing to process development.

Learn more about select members of our team below.



Regis Technologies President & CEO, Louis Glunz
Louis studied chemistry at Notre Dame in the early 80s. Despite plenty of labs, Louis found time to row on the crew team, and twice competed in the Head of the Charles Regatta in Boston. Louis joined Regis in 1993 to sell chromatography products. He held some lectures with Bill Pirkle (University of Illinois) and Jorgen Hermannson (Chrom Tech). Louis also worked on customer synthesis deals and planned infrastructure expansions. He really enjoys seeing Regis add new capabilities. Louis lives in Chicago with his wife and two small children. 



Regis Technologies CFO, COO, Burr Martin
Burr Martin joined Regis Technologies, Inc. as Chief Financial Officer in May 2006. In this role, he was responsible for the financial operations of the company, including accounting, financial planning, treasury, and risk management. In the years following, he assumed responsibility for manufacturing and business development as Chief Operating Officer.  
Prior to Regis, Burr was Vice President of Corporate Planning & Investment Analysis at RR Donnelley, a global provider of print and print related services. Prior to RR Donnelley, Burr worked in a variety of roles for The Quaker Oats Company, with a focus on international finance and expanding Gatorade into Latin America and Asia. Earlier, he spent five years in Brussels, Belgium setting up a European Coordination Center. He began his career at The Northern Trust Company.
Burr Martin received his Master of Business Administration degree from the University of Chicago and is a graduate of Hamilton College.



Regis Technologies Vice President of Chemistry and Strategy, Joe Miller, Ph.D.
Joe Miller received his Ph.D. in 1982 from the University of California, Davis. He then worked as a post-doctoral research assistant with Professor Ei-ichi Negishi, 2010 Nobel Chemistry Laureate, at Purdue University for two years. He is the author of 30 chemical research publications and two review articles on organoaluminum chemistry and holds 12 US Patents.  
Joe has worked in the chemical industry for more than 30 years, including Procter & Gamble, Ethyl Corporation, Henkel Research Corporation, and Exxon Chemical Company early in his career. The last 20+ years, however, have been spent in the pharmaceutical CDMO business. Since 1995, he has held senior leadership roles in Process Chemical R&D and API manufacturing  at Catalytica-DSM Pharmaceuticals, Pharmacore, Irix Pharmaceuticals-Patheon, and most recent Avista Pharma. Joe joined Regis Technologies in August, 2018, and is responsible for Process Chemistry, Analytical Development, and API Manufacturing.



Regis Technologies Director of Analytical Development, Christine Soulje
Christine has worked in the pharmaceutical industry for over 15 years and with Regis since 2016. She earned her Bachelor’s Degree in Chemistry from Allegheny College with honors, where she was also named an Alden Scholar and Doane Scholar. In 2000, she earned her Ph.D. in Organic Chemistry with a Certificate in Toxicology from Duke University. 
Christine spent the majority of her career at Abbot Laboratories as a research  and analytical chemist, where she was responsible for the analytical method development and validation for drug substances, drug products, and finished dosage form dissolution/drug release and led analytical on a multi-company life cycle management development project. At Abbvie as a senior scientist, she led several development projects in various phases of clinical development for both drug substances and drug products. At Regis, Christine leads our team of eight analytical chemists for method development and transfer, method validation, quality control, and ICH stability studies.



Regis Technologies Director of Research, Igor Likhotvorik
Igor has worked in the pharmaceutical industry for over 20 years. He received both his undergraduate degree in chemical engineering and his Ph.D. in organic chemistry from the Technical University of Ukraine. His postdoctoral studies in organic synthesis and organic chemistry of reactive intermediates were completed at Princeton University and The Ohio State University. Previously Igor has worked as a Senior Research Scientist and GMP Laboratories Manager at deCODE Chemistry, a Principal Chemist and Pilot Plant Manager at Acura Pharmaceuticals, and an Associate Professor and Senior Research Scientist at Kiev Polytechnic Institute.

Igor has worked for Regis as the Director of Research since 2009. He is responsible for leading the Regis Research Team in the pursuit of scalable organic syntheses to support drug development programs. He evaluates chemistry routes, estimates scale-up issues, and suggests alternative routes or reagents. He helps lead the team to study these alternatives and prepares the chemical processes for cGMP manufacture. He also conducts pre-validation variable studies for client programs approaching commercialization. Igor has extensive experience in chemical process research and development and has created robust and efficient processes for API synthesis and production. 



Regis Technologies Solid State Chemistry Director Ron Mueller
Ron has worked in the pharmaceutical industry for over 25 years with over 20 years of Preformulation and Solid State Chemistry experience.  After earning his B.Sc. in Chemistry, he studied Chemistry at the Karlsruhe Institute of Technology in Germany as a Fulbright Student Scholar and Quadrille-Mobay Fellow.  Ron received his Ph.D. in 1990 from the University of Nebraska–Lincoln in Organic Chemistry. 
Ron has led Solid State Chemistry teams to contribute to CMC Regulatory modules for several medications (NDAs/MMAs), Drug Master Files and ANDAs.  He has served in professional affiliations as a volunteer in United States Pharmacopeia, Parenteral Drug Association, Product Quality Research Institute, and as the Chair for Industrial Microscopy at Eastern Analytical Symposium.  He is the co-author on many publications and the co-inventor on several patents and/or patent applications. In March 2019, Ron joined Regis and is utilizing his background from Sanofi-Winthrop, Bristol-Myers Squibb, GlaxoSmithKline, West Pharmaceutical Services and Johnson-Matthey to direct the strategic development of a new Solid State Chemistry department.



Regis Technologies Director of Quality, Daniel Weissmueller
Dan has worked with Regis since 2001. Starting in Quality Control, he quickly advanced through Analytical Method Development, Validation, and Quality Assurance. In his current role, Dan is responsible for Regis’ Quality Assurance Unit. Notable accomplishments include coordinating the transfer of Regis’ analytical department to new laboratories, leading the global CMC regulatory approval efforts for multiple new APIs, and leading Regis through multiple FDA inspections receiving no objectionable findings (i.e. zero Form 483 observations).
Dan earned his Master’s degree in Quality and Regulatory Sciences from Northwestern University and a Bachelor’s degree in Chemistry from Benedictine University. Dan’s education, leadership, and extensive experience with contract manufacturing, regulatory, analytical, and validation provide the foundation for effective quality system management that drives Regis’s quality-minded culture.  



Regis Technologies Associate Director of Quality, Marvin Palu
Marvin has worked in the pharmaceutical industry for over 10 years. He earned his Bachelor’s Degree in Chemistry from California State University—San Marcos. After graduation, he worked at Creative Nail Design Labs (now known as Revlon) doing analytical work.  Marvin relocated to Chicago in 2005 to support his wife’s medical education. 
Marvin has worked for Regis since 2005. His strong analytical skills allowed him to become an asset in the Quality Control Department and he became the QC lead in 2007. During his time as Lead, Marvin developed his managerial skills and improved the efficiency and morale of the department. After becoming the Quality Control Manager in 2013, Marvin strived and succeeded in maintaining the QC lab and personnel  to the highest industry standards. Now, as the Associate Director of Quality Control, he continues to take pride in the QC department and is excited to be part of Regis’ ongoing success.  



Regis Technologies Director of Process Development, Siead Zegar
Siead has worked in the pharmaceutical and fine chemical industry for over 25 years. He received his Bachelor’s Degree from the University of Illinois at Chicago.  Siead began his career as an R&D chemist at Pelron Corporation and was promoted to Production Supervisor where he was responsible for overseeing R&D and production operations.  He joined deCODE, a wholly owned subsidiary of deCODE Genetics as a lab manager and advanced to Associate Director of Process Research and Development.  At deCODE Siead was responsible for overseeing the Process Research and Development group which focused on the development/optimization and scale-up of APIs. 
Siead has worked at Regis since 2009. His career with Regis began as a senior chemist in the chemical development/production group and he has recently been promoted to Manager of Process Development.  Siead oversees the Process Development group and is responsible for the development of new processes and transfer of technology to pilot plant and full scale production.



Regis Technologies Manager of Process Engineering, Dragan Ristic
Dragan is a chemical engineer with over 25 years of industrial experience in process development, technology transfer, and manufacturing of active pharmaceutical ingredients and specialty chemicals.  Prior to joining Regis, Dragan had worked for AstraZeneca in Europe and deCODE Genetics in the Chicago area in different engineering and scientific roles from a process engineer to a director of chemical operations.  He held leadership roles in process optimization and technology transfer from the bench to pilot plant and commercial scale focusing on product quality, practicality and safety.  He also coordinated the Pilot Plant construction, equipment installation, and start up at AstraZeneca.
Dragan is focused on expanding Regis’ capabilities in potent compound handling and processing. 



Regis Technologies Chromatography Applications Scientist, Ed Franklin
Ed is an analytical chemist with over 10 years of experience in chromatography research. He earned his bachelor’s degree in biochemistry from Duquesne University and his Ph.D. in analytical chemistry from the University of North Carolina at Chapel Hill. His research experience includes fundamental investigations of the kinetic performance of modern liquid chromatography materials and their use in small and large molecule applications.
Prior to joining Regis, Ed worked at Restek Corporation as a senior scientist in the HPLC product development group. In his current role, Ed develops HPLC and SFC methods for applications of Regis’ line of chromatography products.



Regis Technologies Plant Manager, Chris Cohodes
Chris has worked in the pharmaceutical industry for 11 years. He earned his Bachelor’s Degrees in Chemical and Biomolecular Engineering and Chemisty from the University of Illinois at Urbana-Champaign and holds a Six Sigma Black Belt.
At Regis, he started as a Development Chemist and then worked as a Production Engineer. He has also worked as a Chemical Process Engineer for ITW. Throughout his tenure at Regis, he has been intimately involved in over 30 projects from process scale up to commercial scale. In 2016, he assumed the role of Plant Manager at Regis and now oversees all plant operations and personnel.



Regis Technologies Director of Project and Account Management, Rebecca Centko
Rebecca has worked in the pharmaceutical industry for over 15 years.  She received her Bachelor’s Degree in Chemistry from the Illinois Wesleyan University. Rebecca joined Pharmacia as a medical chemist and worked in the Combinatorial Chemistry group. There, one of her main responsibilities was to design and synthesize therapeutic agents to treat CNS diseases.
Rebecca has worked for Regis as a Project Manager since 2003. She has been responsible for leading the Project Management group at Regis since 2007. In her tenure at Regis, Rebecca has managed over 100 custom manufacturing projects, ranging from pre-clinical, clinical through validation and commercial.  Rebecca and her team are the primary point of contact for the customer’s at Regis and help ensure Regis maintains focus to guarantee the customers needs are met. These needs include timelines, scope and regulatory requirements. Rebecca and the project management team are also responsible for writing the proposals at Regis.  



Brittany Hayes Regis Technologies
Brittany has worked in the pharmaceutical and associated life science industry for over 18 years.  She received her Bachelor’s Degree in Chemistry from Emory University and her Ph.D. in Organic Chemistry from Wake Forest University. Brittany began her career at CEM Corporation, a microwave instrumentation company. Here, as a Senior Scientist, she explored the influence of microwave irradiation on organic transformations, authored the first educational text on microwave chemistry, managed the synthesis laboratory, and was the primary scientific support for the domestic and international sales force.
After her time with CEM Corporation, Brittany transitioned into Business Development with Novabiochem/EMD Chemicals, the North American operation of Merck KGaA.  After 3 years, she moved into the CDMO industry and spent time at Azopharma, Ricerca, Formex, DSM, and Patheon in various Business Development, Contract and Business Management, and Technical Director roles. Brittany joined Regis in January 2019 to manage the Custom Pharma Business Development team and expand Regis’ global collaborations.



Regis Technologies Director of Chromatography, Scott Anderson
Scott has worked in the chromatography industry for over 20 years. He received his BS degree in Biochemistry from Trinity International University.
Prior to joining Regis, Scott worked at Grace/Alltech where he had a roles in product development and marketing. He developed and marketed new HPLC phases, UHPLC columns, capillary and nanobore HPLC columns, Flash Chromatography products, and Bioprocessing separations products. Scott holds 3 patents and a number of publications in the area of chromatography. In May 2016, Scott joined the chromatography team at Regis and is focused on adding new chiral and achrial chromatography products, LC and GC reagents, and various diagnostic/imaging reagents to Regis’s portfolio.